A panel of live antigens of ten Leptospira spp. reference strains were used: L. interrogans serogroup Canicola serovar Canicola strain H. Utrecht IV, serogroup Hebdomadis serovar Hebdomadis strain Hebdomadis, serogroup Icterohaemorrhagiae serovar Copenhageni strain M20, serogroup Pomona serovar Pomona strain Pomona, serogroup Pyrogenes serovar Pyrogenes strain Salinem, serogroup Sejroe serovar Wolfii strain 3,705 and serogroup Sejroe serovar Hardjo strain Hardjoprajitno, L. borgpeterseni serogroup Ballum serovar Castellonis strain Castellon 3 and serogroup Tarassovi serovar Tarassovi strain Perepelitsin and L. kirschneri serogroup Grippotyphosa serovar Grippotyphosa strain Castellon 3. This panel was developed at 28–30°C in the Ellinghausen-McCullough-Johnson-Harris (EMJH) medium with no more than 15 days of growth. Serial serum dilutions were performed with phosphate-buffered saline (PBS, pH 7.2) starting from 1:100 dilution. The plates were incubated at 37°C for 90 min. After incubation, the serum-antigen mixtures were checked for agglutination under a dark field microscope. Tests were interpreted as positive when agglutination at ≥ 1:200 of at least 50% of the leptospires for any serogroup was observed. The highest serum dilution with >50% agglutination or ≤50% free leptospires, compared to the negative control, was considered the endpoint titer of quantitative MAT.
Quantitative Microagglutination Test for Leptospirosis
A panel of live antigens of ten Leptospira spp. reference strains were used: L. interrogans serogroup Canicola serovar Canicola strain H. Utrecht IV, serogroup Hebdomadis serovar Hebdomadis strain Hebdomadis, serogroup Icterohaemorrhagiae serovar Copenhageni strain M20, serogroup Pomona serovar Pomona strain Pomona, serogroup Pyrogenes serovar Pyrogenes strain Salinem, serogroup Sejroe serovar Wolfii strain 3,705 and serogroup Sejroe serovar Hardjo strain Hardjoprajitno, L. borgpeterseni serogroup Ballum serovar Castellonis strain Castellon 3 and serogroup Tarassovi serovar Tarassovi strain Perepelitsin and L. kirschneri serogroup Grippotyphosa serovar Grippotyphosa strain Castellon 3. This panel was developed at 28–30°C in the Ellinghausen-McCullough-Johnson-Harris (EMJH) medium with no more than 15 days of growth. Serial serum dilutions were performed with phosphate-buffered saline (PBS, pH 7.2) starting from 1:100 dilution. The plates were incubated at 37°C for 90 min. After incubation, the serum-antigen mixtures were checked for agglutination under a dark field microscope. Tests were interpreted as positive when agglutination at ≥ 1:200 of at least 50% of the leptospires for any serogroup was observed. The highest serum dilution with >50% agglutination or ≤50% free leptospires, compared to the negative control, was considered the endpoint titer of quantitative MAT.
Corresponding Organization : Consejo Nacional de Investigaciones Científicas y Técnicas
Other organizations : Ministerio de Salud - Provincia de Buenos Aires, Universidad Nacional del Centro de la Provincia de Buenos Aires
Variable analysis
- Panel of live antigens of ten Leptospira spp. reference strains
- Antibodies against pathogenic Leptospira detected by the Microagglutination Test (MAT)
- Titer of ≥1:200 as a criterion of positivity for leptospirosis in cattle in Argentina
- Incubation of the serum-antigen mixtures at 37°C for 90 min
- Interpretation of tests as positive when agglutination at ≥ 1:200 of at least 50% of the leptospires for any serogroup was observed
- Highest serum dilution with >50% agglutination or ≤50% free leptospires, compared to the negative control, was considered the endpoint titer of quantitative MAT
- Negative control
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!